Keri Yang, Swetha Challagulla, Po-Ya Chuang, Wesley Furnback, Sikander Ailawadhi. "Real-world treatment utilization patterns, discontinuation and healthcare resource utilization of first-line (1L) bruton tyrosine kinase inhibitor (BTKi) therapy in chronic lymphocytic leukemia (CLL): Age-related disparity.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.e19033